semaglutide eye damage A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic anterior Novo's Ozempic linked to rare

They also act on hypothalamic receptors to reduce appetite signaling and slow gastric emptying

Increases Fullness : Promotes feeling fuller after smaller portions

Research shows that those taking tirzepatide for type 2 diabetes lost an average of 8.5%-13% of their body weight, while those taking semaglutide lost around 7%

GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models

Clinical Guidance and Ongoing Research Given the limited data on the specific interaction between NSAIDs and semaglutide, healthcare providers rely on general pharmacological knowledge and patient monitoring